Home > Analytics > THYROCARE TECHNOLOGIES

THYROCARE TECHNOLOGIES
Intrinsic Value | Fundamental Analysis

BOM : 539871     NSE : THYROCARE    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : High [>50%]
Apr 23,2024
Price(EOD): ₹ 643.80
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Hospital & Healthcare Services
MCap: ₹ 3,412.14 Cr
Value of ₹ 1 Lac invested in THYROCARE TECHNOLOGIES
on Apr 23,2019 (price: ₹ 494.80)

₹ 1 L

₹ 1.30 L

1W : -6.6% 1M : -6.1% 1Y : 34.2%
COMMUNITY POLL
for THYROCARE TECHNOLOGIES
Please provide your vote to see the results
THYROCARE TECHNOLOGIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Industry Peers & Returns1W1M1Y
THYROCARE TECHNOLOGIES -6.6% -6.1% 34.2%
APOLLO HOSPITALS ENTERPRISE 3.4% -6.6% 49%
MAX HEALTHCARE INSTITUTE 5.7% -8.7% 59.1%
GLOBAL HEALTH 6.7% -13.1% 164.4%
FORTIS HEALTHCARE 2.6% -6.4% 59.4%
NARAYANA HRUDAYALAYA 2% -9.6% 59.5%
ASTER DM HEALTHCARE 1.9% -6.1% 86.2%
DR LAL PATHLABS 12.9% -7.3% 19.6%
KRISHNA INSTITUTE OF MEDICAL SCIENCES 3.3% -8.3% 51.4%

FUNDAMENTAL ANALYSIS OF THYROCARE TECHNOLOGIES

 
Fundamentals Score
[ Q(TTM): Dec2023, Y: Mar2023
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]

Insights 💡 THYROCARE is one of the top 35% companies with good fundamentals ! Discover More →

VALUATION OF THYROCARE TECHNOLOGIES

 
Valuation Score
[As on : Apr 23,2024 ]

Ratio Consolidated
P/E
P/B
P/S
53.37
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 63.88 Cr
[Latest Qtr - Dec2023 - Consolidated Results ]

6.44
P/B Calculated based on Book Value of Rs 529.77 Cr
[Latest Year - Mar2023 - Consolidated Results ]

6.16
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 553.51 Cr
[Latest Qtr - Dec2023 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 12% undervalued companies ! Discover More →

FAIR VALUE OF THYROCARE TECHNOLOGIES

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
36%
-17%
-16%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF THYROCARE TECHNOLOGIES



THYROCARE TECHNOLOGIES vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF THYROCARE TECHNOLOGIES

Year Debt/Equity ratio
Standalone Consolidated
2023
2022
2021
Avg_3yrs
0
0
0
-
0
0
0
-
[Last Annual Data : Mar2023]
Financial Ratios →

PLEDGED PROMOTER SHARES OF THYROCARE TECHNOLOGIES

Pledged Promoter Shares
100 %
As on : Dec2023

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF THYROCARE TECHNOLOGIES

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-8.96%
-15.8%
-29.13%
-26.84%
5.24%
13.39%
2.86%
2.81%
QtrlyTrend
0
Latest Qtr: Dec2023
Quarterly Result Analysis →


THYROCARE TECHNOLOGIES related INDICES

BSE Indices1W1M1Y
S&P BSE SMALL CAP 2.9% 10.7% 64.6%
S&P BSE MIDSMALLCAP 1.9% 8.5% 63.5%
S&P BSE ALLCAP 1% 4.4% 39.7%
S&P BSE HEALTHCARE -0.9% 1.1% 50.9%
No NSE index found

You may also like the below Video Courses


FAQ about THYROCARE TECHNOLOGIES


Is THYROCARE TECHNOLOGIES good for long term investment?

As on Apr 23,2024, the Fundamentals of THYROCARE TECHNOLOGIES look Strong and hence it may be good for long term investment! See Financial Performance of THYROCARE TECHNOLOGIES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is THYROCARE TECHNOLOGIES UnderValued or OverValued?

As on Apr 23,2024, THYROCARE TECHNOLOGIES is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!

What is the Intrinsic Value of THYROCARE TECHNOLOGIES ?

As on Apr 23,2024, the Intrinsic Value of THYROCARE TECHNOLOGIES is Rs. 770.60 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 474.40
Fair Value [Median EV / Sales Model] : Rs. 774.09
Fair Value [Median Price / Sales Model] : Rs. 770.60
Estimated Median Fair Value of THYROCARE TECHNOLOGIES : Rs. 770.60

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is THYROCARE TECHNOLOGIES trading at a Premium or Discount?

As on Apr 23,2024, THYROCARE TECHNOLOGIES is trading at a Discount of -16% based on the estimates of Median Intrinsic Value!